0000899243-22-003416.txt : 20220127
0000899243-22-003416.hdr.sgml : 20220127
20220127160024
ACCESSION NUMBER: 0000899243-22-003416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220125
FILED AS OF DATE: 20220127
DATE AS OF CHANGE: 20220127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORESHACK KURT
CENTRAL INDEX KEY: 0001832579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39725
FILM NUMBER: 22563100
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARAVAI LIFESCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001823239
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 546-0004
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-25
0
0001823239
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI
0001832579
ORESHACK KURT
C/O MARAVAI LIFESCIENCES HOLDINGS, INC.
10770 WATERIDGE CIRCLE, SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
General Counsel
Class A Common Stock
2021-04-30
5
A
0
E
495
22.95
A
7995
D
Class A Common Stock
2021-10-31
5
A
0
E
542
22.95
A
8537
D
Class A Common Stock
2022-01-25
4
A
0
17000
A
25537
D
Employee Stock Option (Right to Buy)
26.32
2022-01-25
4
A
0
31500
0.00
A
2032-01-25
Class A Common Stock
31500
31500
D
The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c).
Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer.
Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.
/s/ Kurt Oreshack
2022-01-27